IPW
FOLD

Impact Partnership Wealth’s Amicus Therapeutics FOLD Stock Holding History

Impact Partnership Wealth’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,787
Closed -$282K – 395
2025
Q4 		$282K Buy
19,787
+6,766
+52% +$66.5K 0.04% 285
2025
Q3 		$103K Buy
+13,021
New +$92.7K 0.02% 301

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Impact Partnership Wealth's FOLD Position: Q1 2026 in Review

Impact Partnership Wealth sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 19,787 shares — an estimated $282K sold.

Impact Partnership Wealth first reported a position in FOLD in Q3 2025 and held it in 2 quarters. The position peaked at $282K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Impact Partnership Wealth reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Impact Partnership Wealth sold 19,787 Amicus Therapeutics shares in Q1 2026, an estimated $282K.
  • Impact Partnership Wealth first reported a position in Amicus Therapeutics in Q3 2025 and held it in 2 quarters.
  • Impact Partnership Wealth's Amicus Therapeutics position peaked at $282K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.